Frequent detection of ras and p53 mutations in brush cytology samples from lung cancer patients by a restriction fragment length polymorphism- based 'enriched PCR' technique

Clinical Cancer Research

Volumn 4, Issue 2, 1998, Pages 361-371

  Behn, Moira ^a   Qun, Shen ^a   Pankow, Wulf ^b   Havemann, Klaus ^a   Schuermann, Marcus ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b VIVANTES KLINIKUM NEUKÖLLN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53; RAS PROTEIN;

ADULT; AGED; ARTICLE; BRONCHOSCOPY; CANCER CYTODIAGNOSIS; CANCER GENETICS; CLINICAL ARTICLE; FEMALE; GENE MUTATION; HUMAN; HUMAN TISSUE; LUNG BIOPSY; LUNG CANCER; MALE; ONCOGENE RAS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

AGED; AGED, 80 AND OVER; ALLELES; BIOPSY; CODON; CYTOLOGICAL TECHNIQUES; DNA PRIMERS; EXONS; FEMALE; GENES, P53; GENES, RAS; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; SENSITIVITY AND SPECIFICITY; TUMOR CELLS, CULTURED;

EID: 0031938494     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Gazdar, A. F. Molecular markers for the diagnosis and prognosis of lung cancer. Cancer (Phila.), 69: 1592-1599, 1992.
2. Johnson, B. E., and Kelley, M. J. Overview of genetic and molecular events in the pathogenesis of lung cancer. Chest, 103 (Suppl.): 1s-3s, 1993.
3. Minna, J. D. The molecular biology of lung cancer pathogenesis. Chest, 103 (Suppl.): 449s-456s, 1993.
4. Gazdar, A. F., Bader, S., Hung, J., Kishimoto, Y., Sekido, Y., Sugio, K., Virmani, A., Fleming, J., Carbone, D. P, and Minna, J. D. Molecular genetic changes found in human lung cancer and its precursor lesions. Cold Spring Harbor Symp. Quant. Biol., 59: 565-572, 1994.
5. Rodenhuis, S., Slebos, R. J., Boot, A. J., Evers, S. G., Mooi, W. J., Wagenaar, S. S., Van Bodegom, P. C., and Bos, J. L. Incidence and possible clinical significance of K-ras oncogene activation in adenocarcinoma of the human lung. Cancer Res., 48: 5738-5741, 1988.
6. Mitsudomi, T., Viallet, J., Mulshine, J. L., Linnoila, R. I., Minna, J. D., and Gazdar, A. F. Mutations of ras genes distinguish a subset of non-small-cell lung cancer cell lines from small-cell lung cancer cell lines. Oncogene, 6: 1353-1362, 1991.
7. Rodenhuis, S., and Slebos, R. J. Clinical significance of ras oncogene activation in human lung cancer. Cancer Res., 52 (Suppl.): 2665s-2669s, 1992.
8. Husgafvel-Pursiainen, K., Hackman, P., Ridanpaa, M. Anttila, S., Karjalainen, A., Partanen, T., Taikina, Aho, O., Heikkila, L., and Vainio, H. K-ras mutations in human adenocarcinoma of the lung: association with smoking and occupational exposure to asbestos. Int. J. Cancer., 53: 250-256, 1993.
9. Li, S., Rosell, R., Urban, A., Font, A., Ariza, A., Armengol, P., Abad, A., Navas, J. J., and Monzo, M. K-ras gene point mutation: a stable tumor marker in non-small cell lung carcinoma. Lung Cancer, 11: 19-27, 1994.
10. Mills, E. N., Fishman, C. L., Rom, W. N., Dubin, N., and Jacobson, D. R. Increased prevalence of K-ras oncogene mutations in lung adenocarcinoma. Cancer Res., 55: 1444-1447, 1995.
11. Mao, L., Hruban, R. H., Boyle, J. O., Tockman, M., and Sidransky, D. Detection of oncogene mutations in sputum precedes diagnosis of lung cancer. Cancer Res., 54: 1634-1637, 1994.
12. Chiba, L., Takahashi, T., Nau, M. M., D'Amico, D., Curiel, D. T., Mitsudomi, T., Buchhagen, D., Carbone, D., Piantadosi, S., Koga, H., Reissman, P. T., Slamon, D. J., Holmes, D. J., and Minna, J. D. Mutations in the p53 gene are frequent in primary, resected non-small cell lung cancer. Oncogene, 5: 1603-1610, 1990.
13. Tahahashi, T. Suzuki, H., Hida, T., Sekido, Y., Ariyoshi, Y., and Ueda, R. The p53 gene is very frequently mutated in small-cell lung cancer with a distinct nucleotide substitution pattern. Oncogene, 6: 1775-1778, 1991.
14. Marchetti, A., Buttitta, F., Merlo, G., Diella, F., Pellegrini, S., Pepe, S., Macchiarini, P., Chella, A., Angeletti, C. A., Callahan, R., Bistocchi, M., and Squartini, F. p53 alterations in non-small cell lung cancers correlate with metastatic involvement of hilar and mediastinal lymph nodes. Cancer Res., 53: 2846-2851, 1993.
15. Top, B., Mooi, W. J., Klaver, S. G., Boerrigter, L., Wisman, P., Elbers, H. R., Visser, S., and Rodenhuis, S, Comparative analysis of p53 gene mutations and protein accumulation in human non-small-cell lung cancer. Int. J. Cancer, 64: 83-91, 1995.
16. Wiethege, T. Voss, B., and Müller, K. M. p53 accumulation and proliferating-cell nuclear antigen expression in human lung cancer. J. Cancer Res. Clin. Oncol., 121: 371-377, 1995.
17. Greenblatt, M. S., Bennett, W. P., Hollstein, M., and Harris C. C. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res., 54: 4855-4878, 1994.
18. Sugio, K., Kishimoto, Y., Virmani, A. K., Hung, J. Y., and Gazdar, A. F. K-ras mutations are a relatively late event in the pathogenesis of lung carcinomas. Cancer Res., 54: 5811-5815, 1994.
19. Sozzi, G., Miozzo, M., Donghi, R., Pilotti, S., Cariani, C. T., Pastorino, U., Della Porta, G., and Pierotti, M. A. Deletions of 17p and p53 mutations in preneoplastic lesions of the lung. Cancer Res., 52: 6079-6082, 1992.
20. Walker, C., Robertson, L. J., Myskow, M. W., Pendleton, N., and Dixon, G. R. p53 expression in normal and dysplastic bronchial epithelium and in lung carcinomas. Br. J. Cancer, 70: 297-303, 1994.
21. Fontanini, G., Vignati, S., Bigini, D., Merlo, G. R., Ribecchini, A., Angeletti, C. A., Basolo, F., Pingitore, R., and Bevilacqua, G. Human non-small cell lung cancer: p53 protein accumulation is an early event and persists during metastatic progression. J. Pathol., 174: 23-31, 1994.
22. Kahn, S. M., Jiang, W., Culbertson, T. A., Weistein, I. B., Williams, G. M., Tomita, N., and Ronai, Z. Rapid and sensitive nonradioactive detection of mutant K-ras genes via "enriched" PCR amplification. Oncogene, 6: 1079-1083, 1991.
23. Levi, S., Urbano-Ispizua, A., Gill, R., Thomas, D. M., Gilbertson, J., Foster, C., and Marshall, C. J. Multiple K-ras codon 12 mutations in cholangiocarcinomas demonstrated with a sensitive polymerase chain reaction technique. Cancer Res., 51: 3497-3502, 1991.
24. Jacobson, D. R., and Mills, N. E. A highly sensitive assay for mutant ras genes and its application to the study of presentation and relapse genotypes in acute leukemia. Oncogene, 9: 553-563, 1994.
25. Mills, N. E., Fishman, C. L., Scholes, J., Anderson, S. E., Rom, W. N., and Jacobson, D. R. Detection of K-ras oncogene mutations in bronchoalveolar lavage fluid for lung cancer diagnosis. J. Natl. Cancer Inst. (Bethesda), 87: 1056-1060, 1995.
26. Mitsudomi, T., Steinberg, S. M., Nau, M. M., Carbone, D., D'Amico, D., Bodner, S., Oie, H., Linnoila, R. I., Mulshine, J. L., Minna, J. D., and Gazdar, A. F. p53 gene mutations in non-small-cell lung cancer cell lines and their correlation with the presence of ras mutations and clinical features. Oncogene, 7: 171-180, 1992.
27. Bepler, G., Jacques, G., Koehler, A., Gropp, C., and Havemann, K. Characterization of the state of differentiation of six newly established human non-small cell lung cancer cell lines. Differentiation, 37: 158-171, 1988.
28. Barnes, W. M. PCR amplification of up to 35-kb DNA with high fidelity and high yield from X bacteriophage templates. Proc. Natl. Acad. Sci. USA, 91: 2216-2220, 1994.
29. Cheng, S., Fockler, C., Barnes, W. M., and Higuchi, R. Effective amplification of long targets from cloned inserts and human genomic DNA. Proc. Natl. Acad. Sci. USA, 91: 5695-5699, 1994.
30. Keohavong, P., DeMichele, M. A. A., Melacrinos, A. C., Landreneau, R. J. Weyant, R. J., and Siegfried, J. M. Detection of K-ras mutations in lung carcinomas: relationship to prognosis. Clin. Cancer Res., 2: 411-418, 1996.
31. Slaughter, D. P., Southwick, H. W., and Smejkal, W. Field cancerization in oral stratified squamous epithelium. Cancer (Phila.), 6: 693-698, 1953.
32. Smith, A. L., Hung, J., Walker, L., Rogers, T. E., Vuitch, F., Lee, E., and Gazdar, A. F. Extensive areas of aneuploidy are present in the respiratory epithelium of lung cancer patients. Br. J. Cancer, 73: 203-209, 1996.
33. Wandel, F., Estreicher, A., Bron, L., Flaman, J-M., Fontolliet, C., Monnier, P., Frebourg, T., and Iggo, R. Field cancerisation and polyclonal p53 mutation in the upper aerodigestive tract. Oncogene, 14: 163-169, 1997.
34. Li, Z. H., Zheng, J., Weiss, L. M., and Shibata, D. c-k-ras, and p53 mutations occur very early in adenocarcinoma of the lung. Am. J. Pathol., 144: 303-309, 1994.